February 12, 2026
Headlines

What’s Going On With Palisade Bio Stock On Thursday?

01 mins

Palisade Bio progresses its Phase 1 study for PALI-2108, showing safety and targeted bioactivation, with topline data anticipated in early 2025.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News